Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05642364 · ClinicalTrials.gov registry record · NA

Virtual Reality in Hemodialysis to Improve Psychological Well-being

A NA study of Depressive Symptoms and End-Stage Kidney Disease, sponsored by University of Illinois at Urbana-Champaign.

Active
Registry status
NA
Development phase
61
Enrollment target
3
Study locations

NCT05642364 is a NA study of Depressive Symptoms and End-Stage Kidney Disease that is active but no longer recruiting, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 61 participants, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05642364, a NA study of Depressive Symptoms and End-Stage Kidney Disease, is active but no longer recruiting, sponsored by University of Illinois at Urbana-Champaign.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
61 participants
Enrollment target
3
Study locations

Study Summary

The long-term goal is to create behavioral health technologies to advance the science that leverages state-of-the-art technology to delivery psychotherapeutic treatment to individuals on hemodialysis (HD) to improve their emotional well-being, quality of life, and overall health. The objective in this small R01 study is to design a virtual reality (VR) platform, that fully immerses users into a fictitious lifelike environment, to deliver an evidence-based positive psychological intervention and to test whether it improves the emotional well-being of individuals on HD with comorbid depression. In this proposed 2-arm randomized controlled trial, the investigators hypothesize that delivery of psychotherapy in individuals on HD using a VR environment will prove feasible and will result in significant improvements in depressive symptoms, quality of life, and treatment adherence, along with reduced rates of hospitalization when compared to an active control condition-all while serving as a cost-effective and far-reaching platform for expansive dissemination. The Specific Aims are: Aim #1: To develop VR software to immersively deliver the skills taught in a 5-week evidence-based positive psychological intervention in individuals on HD to improve their emotional well-being. Aim #2: To evaluate the acceptability and feasibility of a 5-week positive psychological intervention, delivered using a VR platform through consideration of rates of recruitment, refusal, retention, (non)compliance, and adherence. Aim #3: To test initial efficacy of the VR-based psychotherapeutic intervention, compared to a control arm, on outcomes of depression, psychological well-being, quality of life, treatment adherence, HD sessions missed, and hospitalizations in HD patients. Knowledge gained from completion of the proposed research will result in the first VR software application to deliver psychotherapy to individuals on HD, while simultaneously allowing them to leave the confines of the cl

Interventions

  • BEHAVIORAL Joviality(TM)
  • OTHER Inert Virtual Reality

Study Locations (3)

Illinois

  • DaVita Little Village Dialysis PD - Chicago
  • UI Health - Dialysis Unit, EEI Suite 2028 - Chicago
  • DaVita Garfield Kidney Center - Chicago

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2023-06-22
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT05642364

The ClinicalTrials.gov registry entry for NCT05642364 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (77% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Joviality(TM) is the first listed.

NCT05642364 reports 3 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05642364 about?

NCT05642364 is a clinical study titled "Virtual Reality in Hemodialysis to Improve Psychological Well-being". The long-term goal is to create behavioral health technologies to advance the science that leverages state-of-the-art technology to delivery psychotherapeutic treatment to individuals on hemodialysis (HD) to improve their emotional well-being, quality of life, and overall health. The objective in th...

What is the current status of trial NCT05642364?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2023-06-22. Estimated completion is 2026-03-31.

What conditions does trial NCT05642364 study?

This clinical trial studies the following conditions: Depressive Symptoms, End-Stage Kidney Disease.

What interventions are being tested in trial NCT05642364?

The interventions under investigation include: Joviality(TM) (BEHAVIORAL), Inert Virtual Reality (OTHER).

Who is sponsoring clinical trial NCT05642364?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05642364 being conducted?

This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.